Mike Pishvaian, MD, PhD
Gastrointestinal Oncologist, Co-Director, Pancreatic Cancer Program at the Reusch Center, Phase I Program
Director and Assistant Professor, Lombardi Comprehensive Cancer Center
Georgetown University, Washington, D.C.
Mike Pishvaian is a gastrointestinal oncologist, Co-Director of the Pancreatic Cancer Program at the Ruesch Center, and head of the Phase I Program at the Lombardi Comprehensive Cancer Center. Dr. Pishvaian is an MD and a PhD in Tumor Biology, and earned both degrees at Georgetown in 2001. He has been at Georgetown since graduating, completing his medical residency in 2004, then his fellowship in Hematology/Oncology in 2007.
Dr. Pishvaian is a translational oncologist, focused on providing novel therapy for patients, particularly in the areas of pancreatic cancer, and refractory colorectal cancer. Dr. Pishvaian is the Principal Investigator of numerous Phase I and Phase II clinical trials. In particular, he is the National lead in several multi-institutional trials in pancreatic cancer, and recently received an AACR-PanCAN Research Acceleration Network award to lead a clinical trial of molecularly tailored therapy for patients with metastatic pancreatic cancer.